These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18083230)

  • 21. Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.
    Tseng PH; Lin HP; Zhu J; Chen KF; Hade EM; Young DC; Byrd JC; Grever M; Johnson K; Druker BJ; Chen CS
    Blood; 2005 May; 105(10):4021-7. PubMed ID: 15665113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of hydroxyurea combined with interferon-alpha on growth and apoptosis-related oncogene expression of K562 cells].
    Chen H; Luo Z; Luo S
    Zhonghua Yi Xue Za Zhi; 2000 Aug; 80(8):606-9. PubMed ID: 11798827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T
    Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V; Handrick R; Belka C
    FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-KIT-expressing Ewing tumour cells are insensitive to imatinib mesylate (STI571).
    Hotfilder M; Lanvers C; Jürgens H; Boos J; Vormoor J
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):167-9. PubMed ID: 12172985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S
    Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571.
    Wozniak K; Czechowska A; Blasiak J
    Chem Biol Interact; 2004 Apr; 147(3):309-18. PubMed ID: 15135086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line.
    Tarumoto T; Nagai T; Ohmine K; Miyoshi T; Nakamura M; Kondo T; Mitsugi K; Nakano S; Muroi K; Komatsu N; Ozawa K
    Exp Hematol; 2004 Apr; 32(4):375-81. PubMed ID: 15050748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibitory effects of celecoxib combined with octreotide on growth of multidrug resistant human gastric cancer cell line SGC7901/ADR].
    Zheng WB; Wang CH; Qiang O; Tang CW
    Ai Zheng; 2004 Dec; 23(12):1628-32. PubMed ID: 15601550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro.
    Ferrao PT; Frost MJ; Siah SP; Ashman LK
    Blood; 2003 Dec; 102(13):4499-503. PubMed ID: 12881321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
    Kawano T; Horiguchi-Yamada J; Saito S; Iwase S; Furukawa Y; Kano Y; Yamada H
    Leuk Res; 2004 Jun; 28(6):623-9. PubMed ID: 15120940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
    Sawafuji K; Miyakawa Y; Weisberg E; Griffin JD; Ikeda Y; Kizaki M
    Leuk Lymphoma; 2003 Nov; 44(11):1987-96. PubMed ID: 14738154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Berbamine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo.
    Wei YL; Xu L; Liang Y; Xu XH; Zhao XY
    Acta Pharmacol Sin; 2009 Apr; 30(4):451-7. PubMed ID: 19270722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
    Johnson FM; Yang P; Newman RA; Donato NJ
    J Exp Ther Oncol; 2004 Dec; 4(4):317-25. PubMed ID: 15844661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
    Dandekar DS; Lopez M; Carey RI; Lokeshwar BL
    Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase II inhibitors adriamycin and etoposide].
    Meliksetian MB; Berezkina EV; Pavlenko MA; Grinchuk TM
    Tsitologiia; 1999; 41(7):615-21. PubMed ID: 10496023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells.
    Wu T; Leng J; Han C; Demetris AJ
    Mol Cancer Ther; 2004 Mar; 3(3):299-307. PubMed ID: 15026550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanism of STI571 inducing apoptosis of K562 cells.
    Qin Y; Chen S; Chang Y; Fu J; Wang X
    Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):289-92. PubMed ID: 12411057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of apoptosis induced by indomethacin in chronic myeloid leukemia].
    Tu C; Zhang G; Lu H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):362-5. PubMed ID: 11721434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.